The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system
- 31 December 2011
- journal article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 65 (6), 1117-1125
- https://doi.org/10.1016/j.jaad.2010.09.017
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- iPLEDGE Allegiance to the Pill: Evaluation of Year 1 of a Birth Defect Prevention and Monitoring SystemThe Journal of Law, Medicine & Ethics, 2009
- What Is the Chance of a Normal Pregnancy in a Woman Whose Fetus Has Been Exposed to Isotretinoin?Archives of Dermatology, 2007
- Guidelines of care for acne vulgaris managementJournal of the American Academy of Dermatology, 2007
- What Is the Best Approach to Reducing Birth Defects Associated with Isotretinoin?PLoS Medicine, 2006
- A risk management program aimed at preventing fetal exposure to isotretinoin: Retrospective cohort studyJournal of the American Academy of Dermatology, 2006
- Guidelines for treating acneClinics in Dermatology, 2004